|Articles|July 1, 2001
- Applied Clinical Trials-07-01-2001
Affairs of State
As FDA monitors more international clinical trials, new policies aim to address differences in national approaches to such issues as placebos and protocols.
Advertisement
Articles in this issue
over 24 years ago
Letters to the Editorover 24 years ago
Conference Reportsover 24 years ago
Pen-Based Computingover 24 years ago
Some Do--Some Watch Over Those Who Doover 24 years ago
Communication Skills for Monitors—A Vital Training Opportunityover 24 years ago
ACT 101 Human Safety in Clinical ResearchNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
Using AI and Tokenized Data to Match Patients to Protocols
4
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
